Morales, Noravella B.

HRN: 23-16-84  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/28/2023
MEBENDAZOLE 500MG (TAB)
06/28/2023
07/01/2023
PO
500mg
2 Tabs Now Then 1 Tab OF X 3 Doses
Biliary Ascariasis
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: